Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

Treating initially unresectable gastric or GEJ cancer with camrelizumab plus nab-POF led to an R0 resection rate of 75% in a phase 2 trial.

Adding evorpacept to treatment with trastuzumab, ramucirumab, and paclitaxel may improve outcomes in HER2-positive gastric/GEJ cancer.

(HealthDay News) — On Monday, President Donald Trump issued an executive order withdrawing the United States from the World Health Organization (WHO). The executive order retracts a Presidential ...

Apologies can help improve the quality of the treatment relationship by restoring trust and sharing power with the patient.

Perioperative chemotherapy improved outcomes when compared to preoperative chemoradiotherapy in a phase 3 trial of patients with resectable esophageal cancer. Results from this tr ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

The lower payments female oncologists received may reflect a “disadvantage in terms of career trajectories for women,” according to researchers.

Under former President Joe Biden, enrollment in Medicaid hit a record high, and the uninsured rate reached a record low. President Donald Trump’s return to the White House — along with a ...

A growing body of research suggests that exposure to PFAS, commonly called "forever chemicals," may increase a person's risk ...

The FDA has approved Datroway (datopotamab deruxtecan) to treat adults with unresectable or metastatic, HR+, HER2- breast cancer who have received prior endocrine therapy and chemotherapy.